Patient info

Buttercup Bronchostop Cough Pastilles – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
General sale (GSL)
Medicine strength:
59.5 mg
Contains active substance:

Patient leaflet - Buttercup Bronchostop Cough pastilles

1. WHAT BUTTERCUP BRONCHOSTOP COUGH

PASTILLES ARE AND WHAT THEY ARE USED FOR

Buttercup Bronchostop Cough Pastilles are a

traditional herbal medicinal product used for the relief

of coughs, such as chesty coughs and dry, tickly,

irritating coughs and catarrh based on traditional use

only.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BUTTERCUP BRONCHOSTOP COUGH PASTILLES

Do not take Buttercup Bronchostop Cough

Pastilles

  • If you are allergic to Thyme or other members

    of the Lamiaceae family (e.g. Basil, Rosemary,

    Sage), or to any of the other ingredients of this

    medicine (listed in section 6).

  • If you are pregnant or breast-feeding.

Warnings and precautions

Consult your doctor before taking Buttercup

Bronchostop Cough Pastilles if you:

  • are prone to develop allergic reactions. There is a

    possible risk that this medicine may trigger severe

    and life-threatening allergic reactions in patients

    who have a tendency to develop allergic reactions.

  • have asthma, as Buttercup Bronchostop Cough

    Pastilles may make asthma symptoms worse.

Children

Do not give this medicine to children under 12 years.

Other medicines and Buttercup Bronchostop

Cough Pastilles

Tell your doctor or pharmacist if you are taking, have

recently taken or might take any other medicines,

including medicines obtained without a prescription.

Pregnancy and breast-feeding

Do not take this medicine if you are pregnant or

breast-feeding.

Driving and using machines

No studies on the effects on the ability to drive and to use machines have been performed. Buttercup Bronchostop Cough Pastilles contain no ingredients that are known to cause drowsiness.

Buttercup Bronchostop Cough Pastilles contain fructose and sorbitol

This medicine contains 523 mg sorbitol and 300 mg fructose in each pastille, corresponding to approximately 0.1 carbohydrate unit. This should be considered in patients with diabetes mellitus. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.

Buttercup Bronchostop Cough Pastilles contain propylene-glycol (E1520)

The medicine contains 5.53 mg of propylene-glycol in each pastille.

Buttercup Bronchostop Cough Pastilles contain benzyl-alcohol (E1519)

This medicine contains 0.0018 mg benzyl-alcohol (E1519) in each pastille. Benzyl-alcohol (E1519) may cause allergic reactions.

Buttercup Bronchostop Cough Pastilles contain sodium

This medicine contains less than 1 mmol sodium (23 mg) per pastille, that is to say essentially ‘sodium-free’.

3. HOW TO TAKE BUTTERCUP BRONCHOSTOP COUGH PASTILLES

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or qualified healthcare practitioner has told you. Check with your

doctor, pharmacist or qualified healthcare practitioner if you are not sure.

For oral use (allow to dissolve in the mouth through sucking).

Dosage

Adults, the elderly and children over 12 years:

1 – 2 pastilles to be taken every 4 hours, 4 times a day. If required, up to a maximum of 12 pastilles can be taken per day.

Do not give to children under 12 years.

DO NOT EXCEED THE STATED DOSE.

You must talk to a doctor or qualified healthcare practitioner if you do not feel better or if you feel worse after 7 days.

If you are short of breath, have a high temperature (fever), your phlegm is yellow-green or brown in colour (purulent sputum), you must consult your doctor or qualified healthcare practitioner.

If you take more Buttercup Bronchostop Cough Pastilles than you should

Talk to a doctor straight away, or contact your nearest hospital casualty department.

Take the carton and this leaflet with you.

If you forget to take Buttercup Bronchostop Cough Pastilles

Take the next dose when it is due. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them. The frequency of the following side effects occurring is not known.

This medicine may cause the following serious allergic reactions. If you experience any of the following effects, stop taking the pastille and seek medical advice immediately:

  • severe and potentially life-threatening reactions, with symptoms that may include feeling lightheaded or faint, breathing difficulties or wheezing, a fast heartbeat, skin rash, confusion and anxiety, or loss of consciousness (anaphylactic reaction)
  • swelling of the face, lips, tongue, mouth or throat (angioedema),
  • blistering of the mouth and throat
  • worsening of asthma symptoms
  • difficulty breathing (including shortness of breath) Other possible side effects:

If any of the following side effects get serious or concerns you, or you notice any other side effect, stop taking the pastilles and seek medical advice as soon as possible:

  • Allergic skin reactions including urticaria (red bumps on the skin), and itching. Gastrointestinal disorders such as pain or discomfort in the abdomen, diarrhoea, vomiting, and nausea. Reporting of side effects

If you get any side effects, talk to your doctor,

pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE BUTTERCUP BRONCHOSTOP COUGH PASTILLES

Do not store above 25°C. Store the blister in the original package in order to protect from light. Keep out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION What Buttercup Bronchostop Cough Pastilles contain

Each pastille contains the active ingredient: 59.5mg of extract (as dry extract) from Thyme herb (Thymus vulgaris L. and Thymus zygis L.,herb) (DER 7-13:1) Extraction solvent: water.

Each pastille also contains 300 mg of fructose and 523 mg of sorbitol.

The other ingredients are:

Maltodextrin, Arabic gum, Fructose, Sorbitol liquid non-crystallising (E420), Citric acid anhydrous, Saccharin sodium, Aronia (chokeberry) flavour (which contains propylene-glycol (E1520)), Fruit of forest (berry) flavour (propylene-glycol (E1520) and benzyl-alcohol (E1519), Paraffin light liquid, Purified water.

What Buttercup Bronchostop Cough Pastilles look like and contents of the package

Buttercup Bronchostop Cough Pastilles are hexagonal, brown pastilles.

Buttercup Bronchostop Cough Pastilles are available in blister packs containing 10, 20 or 40 pastilles. Not all pack sizes may be marketed.

THR Holder

Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL, UK.

Manufacturer

Kwizda Pharma GmbH, Effingergasse 21 1160 Vienna, Austria

Distributed by Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL, UK.

THR 02855/0337

Is this leaflet hard to see or read?

Phone 01748 828860 for help.

This leaflet was revised in September 2022. Certification Mark

LF06444G / 22151-08_UK / 917

File title: 11409_LF06444G_CR07552_Bronchostop Pastilles_10s_Leaflet_UK v01 Item No.: 22151-08_UK

OPI No.: LF06444G

Replacement No.: 22151-07_UK

Last edit: 27th July 2022

Brand: Bronchostop

Variant: Cough Pastilles

Component: Leaflet

Market/s: UK

Dimensions: 148 x 210 mm

Spec. Ref.: …

Substrate: …

EAN Code: …

Other Code/Spec.: …

Manufacturing Site: Kwizda

No. of Colours: 1

Black Cutter

512 Metal Box Factory,

30 Great Guildford Street,

London, SE1 0HS, UK

+44 (0)20 3982 8471 london@oneagency.co

Body copy size: 8pt Body copy leading: 8.5pt Body copy horizontal scale: 88%

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: THR028550337

Last revision stated in the text: September 2022 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Buttercup Bronchostop Cough pastilles

Prescription needed? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substance Thyme
Strength 59.5 mg
Pharmaceutical form Pastille
How is it taken Oromucosal
Excipients Excipients of the herbal preparation, Maltodextrin, Arabic gum, Excipients of the herbal product, Fructose, Sorbitol liquid 70% non-crystallising (E420) Citric acid anhydrous, Saccharin sodium, Aronia (chokeberry) flavour (which contains propylene glycol (E1520)) Fruit of the forest (berry) aroma flavour (which contains propylene glycol (E1520) and benzyl-alcohol (E1519)) Paraffin, light liquid, Purified water
Pack sizes 10 pastille, 20 pastille, 40 pastille
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage Do not store above 25°C.
Store blister in the original package in order to protect from light. .
Marketing authorisation THR 02855/0337 (first authorised 27 January 2014)
Marketing authorisation holder Omega Pharma Ltd.
Codes GTIN 5012616262227, 5012616262234, 5012616262241 · BNF 12030300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.